Patents Assigned to Zetagen Therapeutics, Inc.
  • Polysilane methacrylic compounds and methods of making them
    Patent number: 12128064
    Abstract: A polysilane methacrylic polymer and processes of preparing the polysilane methacrylic polymer are provided.
    Type: Grant
    Filed: July 17, 2024
    Date of Patent: October 29, 2024
    Assignee: Zetagen Therapeutics, Inc.
    Inventor: Bryan S. Margulies
  • Polysilane methacrylic compounds and methods of making them
    Patent number: 12109226
    Abstract: A polysilane methacrylic polymer and processes of preparing the polysilane methacrylic polymer are provided.
    Type: Grant
    Filed: April 12, 2024
    Date of Patent: October 8, 2024
    Assignee: Zetagen Therapeutics, Inc.
    Inventor: Bryan S. Margulies
  • Controlled release formulation and minimally invasive method of administration
    Patent number: 12090152
    Abstract: A controlled release formulation comprising an opioid growth factor receptor (OGFR) antagonist and at least one pharmaceutically acceptable carrier has been developed, which is useful for treating cancer when locally administered at a disease site.
    Type: Grant
    Filed: April 15, 2024
    Date of Patent: September 17, 2024
    Assignee: Zetagen Therapeutics, Inc.
    Inventor: Bryan S. Margulies
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20240277699
    Abstract: This disclosure relates to methods and compositions for treating cancer by administering opioid growth factor receptor (OGFR) antagonists. In particular, the present disclosure relates to methods of administering OGFR antagonists locally to the site of cancer cells in the patient diagnosed with cancer.
    Type: Application
    Filed: April 26, 2024
    Publication date: August 22, 2024
    Applicant: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur
  • Methods and compositions for treating cancer
    Patent number: 11980615
    Abstract: This disclosure relates to methods and compositions for treating cancer by administering opioid growth factor receptor (OGFR) antagonists. In particular, the present disclosure relates to methods of administering OGFR antagonists locally to the site of cancer cells in the patient diagnosed with cancer.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: May 14, 2024
    Assignee: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur
  • Controlled release formulation and minimally invasive method of administration to locally treat cancer
    Patent number: 11957676
    Abstract: A controlled release formulation comprising an opioid growth factor receptor (OGFR) antagonist and at least one pharmaceutically acceptable carrier has been developed, which is useful for treating cancer when locally administered at a disease site.
    Type: Grant
    Filed: August 7, 2023
    Date of Patent: April 16, 2024
    Assignee: Zetagen Therapeutics, Inc.
    Inventor: Bryan S. Margulies
  • METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS
    Publication number: 20240016976
    Abstract: A bone graft composition comprising a calcium phosphate putty is provided. A method of repairing a bone defect in a patient by applying the bone graft composition is also provided.
    Type: Application
    Filed: September 6, 2023
    Publication date: January 18, 2024
    Applicant: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur
  • METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS
    Publication number: 20240000996
    Abstract: A bone graft composition comprising a calcium phosphate putty is provided. A method of repairing a bone defect in a patient by applying the bone graft composition is also provided.
    Type: Application
    Filed: September 7, 2023
    Publication date: January 4, 2024
    Applicant: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20230190733
    Abstract: This disclosure relates to methods and compositions for treating cancer by administering opioid growth factor receptor (OGFR) antagonists. In particular, the present disclosure relates to methods of administering OGFR antagonists locally to the site of cancer cells in the patient diagnosed with cancer.
    Type: Application
    Filed: October 17, 2022
    Publication date: June 22, 2023
    Applicant: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur
  • Methods and compositions for treating cancer
    Patent number: 11471454
    Abstract: This disclosure relates to methods and compositions for treating cancer by administering opioid growth factor receptor (OGFR) antagonists. In particular, the present disclosure relates to methods of administering OGFR antagonists locally to the site of cancer cells in the patient diagnosed with cancer.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: October 18, 2022
    Assignee: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur
  • METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS
    Publication number: 20220016312
    Abstract: A bone graft composition comprising a calcium phosphate putty is provided. A method of repairing a bone defect in a patient by applying the bone graft composition is also provided.
    Type: Application
    Filed: January 7, 2021
    Publication date: January 20, 2022
    Applicant: Zetagen Therapeutics, Inc.
    Inventors: Bryan S. Margulies, Nikhil A. Thakur